Stan Heptinstall

9.2k total citations · 1 hit paper
129 papers, 4.3k citations indexed

About

Stan Heptinstall is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Pharmacology. According to data from OpenAlex, Stan Heptinstall has authored 129 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cardiology and Cardiovascular Medicine, 43 papers in Hematology and 27 papers in Pharmacology. Recurrent topics in Stan Heptinstall's work include Antiplatelet Therapy and Cardiovascular Diseases (67 papers), Platelet Disorders and Treatments (40 papers) and Inflammatory mediators and NSAID effects (23 papers). Stan Heptinstall is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (67 papers), Platelet Disorders and Treatments (40 papers) and Inflammatory mediators and NSAID effects (23 papers). Stan Heptinstall collaborates with scholars based in United Kingdom, Germany and United States. Stan Heptinstall's co-authors include Robert F. Storey, Jane May, Ann E. White, Håkan Emanuelsson, Steen Husted, Mark Wickens, Gary Peters, Per Morten Sandset, W. Antoinette Groenewegen and Robert A. Wilcox and has published in prestigious journals such as The Lancet, Circulation and Biochemical and Biophysical Research Communications.

In The Last Decade

Stan Heptinstall

127 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

2006 575 citations Steen Husted, Håkan Emanuelsson et al. profile →

Peers

Countries citing papers authored by Stan Heptinstall

Since Specialization

Citations

This map shows the geographic impact of Stan Heptinstall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan Heptinstall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan Heptinstall more than expected).

Fields of papers citing papers by Stan Heptinstall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stan Heptinstall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan Heptinstall. The network helps show where Stan Heptinstall may publish in the future.

Co-authorship network of co-authors of Stan Heptinstall

This figure shows the co-authorship network connecting the top 25 collaborators of Stan Heptinstall. A scholar is included among the top collaborators of Stan Heptinstall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stan Heptinstall. Stan Heptinstall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PAMFix, a fixative developed to enable remote platelet function testing: uses and applications 2015 ·Nottingham ePrints (University of Nottingham) ·Stan Heptinstall, Susan C. Fox, Jane May, Ann E. White, Natalia Dovlatova	2
2	Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders 2014 ·Journal of Thrombosis and Haemostasis ·Natalia Dovlatova, Marie Lordkipanidzé, Gillian Lowe, Ban B. Dawood, Jane May, Stan Heptinstall, Steve P. Watson, Susan C. Fox	39
3	Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y₁₂antagonist bothin-vitroandex-vivoin human volunteers 2012 ·Platelets ·Sue Fox, Jane May, Andrew J. Johnson, Dirk M. Hermann, (unknown), Dan Hartman, Stan Heptinstall	26
4	PGE₂reverses G_s-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G_s-mediated inhibition of platelet aggregation by interaction with EP4 receptors 2012 ·Platelets ·Jacqueline R. Glenn, Ann E. White, David Iyú, Stan Heptinstall	10
5	Anti‐platelet therapy: ADP receptor antagonists 2011 ·British Journal of Clinical Pharmacology ·Yanushi D. Wijeyeratne, Stan Heptinstall	83
6	Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: A randomised controlled trial in healthy elderly adults 2010 ·Thrombosis Research ·M Samama, Satoshi Kunitada, (unknown), François Depasse, Stan Heptinstall	19
7	Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations inP2RY12, P2RY1,andITGB3 2009 ·Platelets ·Robert F. Storey, (unknown), Rachael Lawrance, Steen Husted, Mark Wickens, Håkan Emanuelsson, Christopher P. Cannon, Stan Heptinstall, Martin Armstrong	49
8	The reversible P2Y12 antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function 2008 ·Journal of Thrombosis and Haemostasis ·Natalia Dovlatova, Joseph A. Jakubowski, Atsuhiro Sugidachi, Stan Heptinstall	80
9	Value of Platelet Activation Markers as Prothrombotic Risk Indicators 2007 ·Transfusion Medicine and Hemotherapy ·Wolfgang Lösche, Stan Heptinstall	7
10	Cocoa Flavanols and Platelet and Leukocyte Function: Recent In Vitro and Ex Vivo Studies in Healthy Adults 2006 ·Journal of Cardiovascular Pharmacology ·Stan Heptinstall, Jane May, Sue Fox, Catherine Kwik‐Uribe, Liancheng Zhao	67
11	Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin 2004 ·Thrombosis Research ·Robert F. Storey, Jane May, Stan Heptinstall	16
12	Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1 2003 ·Cell Calcium ·Sue Fox, M. Behan, Stan Heptinstall	62
13	Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice? 1998 ·British Journal of Haematology ·Stan Heptinstall, Ann E. White, Natalie Edwards, Jennifer Pascoe, H. M. Sanderson, Susan C. Fox, R Henderson	27
14	ADP-induced P-selectin expression on platelets as a predictor of successful thrombolysis 1996 ·Blood Coagulation & Fibrinolysis ·Salim Yusuf, (unknown), Stan Heptinstall, Alan T. Nurden, Peter W. Wenham, Brian R. Hopkinson	1
15	Platelet-platelet Contact and Thromboxane A₂Contribute to Actin Polymerization in Platelets Stimulated with ADP 1994 ·Platelets ·Jacqueline R. Glenn, P. Spangenberg, Stan Heptinstall	2
16	Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP 1991 ·European Journal of Pharmacology ·Stephen J. Gray, Stan Heptinstall	27
17	Glucose increases spontaneous platelet aggregation in whole blood 1990 ·Thrombosis Research ·Jane May, Walter J. Loesche, Stan Heptinstall	21
18	An extract of feverfew inhibits interactions of human platelets with collagen substrates 1987 ·Thrombosis Research ·Wolfgang Lösche, А. В. Мазуров, Stan Heptinstall, W. Antoinette Groenewegen, Repin Vs, U Till	16
19	A regimen for low-dose aspirin? 1982 ·BMJ ·S P Hanley, J. Bevan, S R Cockbill, Stan Heptinstall	42
20	CONTRIBUTION OF PLATELETS TO THROMBUS FORMATION 1978 ·British Medical Bulletin ·Aprilfawn White, Stan Heptinstall	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact